Science and Technology Science and Technology
Tue, December 3, 2024
Mon, December 2, 2024
[ Mon, Dec 02nd 2024 ] - Thomas Matters
What is an IPO?
[ Mon, Dec 02nd 2024 ] - Phil Bruner
Read Bollywood News
[ Mon, Dec 02nd 2024 ] - Aaron Neefham
About New Scientist magazine
[ Mon, Dec 02nd 2024 ] - Bill Williamson
Partnership of promise
[ Mon, Dec 02nd 2024 ] - Bill Williamson
Stephanie Colestock
[ Mon, Dec 02nd 2024 ] - Phil Bruner
Watch Samaa News Live

Indian-origin CEO strikes 'significant' UK deal to combat cancer, dementia


Published on 2024-12-02 17:02:28 - Tim Hastings, N@N
  Print publication without navigation

  • Gordon Sanghera, CEO of Oxford Nanopore Technologies, said the development of a world-first "epigenetic map" of the human genome could lead to breakthroughs in new diagnoses and treatments.

The article from India Today discusses how Harpal Kumar, an Indian-origin CEO of the UK-based charity Cancer Research UK, has facilitated a significant deal with the UK government aimed at combating cancer and dementia. This deal, part of a broader initiative to enhance health research, involves a £100 million investment to accelerate the development of new treatments and diagnostics for these diseases. The agreement seeks to leverage the UK's strengths in life sciences to foster innovation, improve patient outcomes, and potentially save lives by advancing research into early detection and personalized medicine. The initiative also aims to create jobs and stimulate economic growth in the health sector.

Read the Full India Today Article at:
[ https://www.indiatoday.in/world/uk-news/story/indian-origin-ceo-strikes-significant-uk-deal-to-combat-cancer-dementia-2643887-2024-12-02 ]